• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

AMPLY: Venture Capital Funding History

AMPLY

To add a bio or update company history, please click update information.

News from AMPLY

    AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solutionAMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution
    AMPLY
    11 Feb 2026

    AMPLY Discovery secures strategic investment from Keeps Biomed for its AI-led oncology drug discovery solution

    AMPLY Discovery applies AI to identify and validate new oncology drug targets. It combines computational analysis with laboratory testing to generate therapeutic programmes for partnering.

    AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugsAMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs
    AMPLY
    1 May 2025

    AMPLY raises £1.3m seed led by Twin Path Ventures to accelerate drug discovery for aggressive cancers and superbugs

    AMPLY builds an AI driven drug discovery platform that combines computational biology, sequencing and lab validation to develop new treatments for aggressive cancers and drug resistant infections.

AMPLY
  • Life Sciences
  • Belfast, United Kingdom
  • amplydiscovery.com
  • Update Information

More venture news

  • Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases
    Oyster Therapeutics
    13 Nov 2026

    Oyster Therapeutics secures a £45m Series A round from CE-Ventures to develop an oral drug for neurodegenerative diseases

    Series ALife Sciences
  • Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
    Neobe Therapeutics
    10 Nov 2026

    Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

    SeedLife Sciences
  • PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
    PhaSER Biomedical
    9 Nov 2026

    PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases

    GrantLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn